to the health care system. Other patients must be dealt with on a
case by case basis weighing up all the individual circumstances.
RReeffeerreennccee
1 Garrett C. A new evidence base for implantable cardioverter defibrillator
therapy. Eur Heart J1998; 1199 : 189–91.
2 National Institute for Clinical Excellence. Guidance on the use of implantable
cardioverter defibrillators for arrhythmias. Technology Appraisal Guidance–
No. 11, September 2000. (www.nice.org.uk)
FFuurrtthheerr rreeaaddiinngg
Bigger JT. Coronary artery bypass grafting (CABG)-patch trial. N Engl J
Med1997; 333377 : 1569–75.
Gregoratos G, Cheitlin MD, Conill A et al. The American College of
Cardiology/American Heart Association practice guidelines for
arrhythmia devices. J Am Coll Cardiol1998; 3311 : 1175–209.
Moss AJ, Hall WJ, Cannom DS et al. Improved survival with an
implanted defibrillator in patients with coronary disease at high risk for
ventricular arrhythmia. The Multi-Center Automated Defibrillator
Implantation (MADIT) Trial. N Engl J Med1996; 333355 : 1933–40.
Zipes DP et al. A comparison of antiarrhythmic-drug therapy with
implantable defibrillators in patients resuscitated from near-fatal
ventricular arrhythmias. The anti-arrhythmics versus implantable defib-
rillators (AVID). N Engl J Med1997; 333377 : 1576–83.